A 54 year old man from New Hampshire received a genetically modified pig kidney transplant on June, 14 at Massachusetts General Hospital. The surgery is part of experimental xenotransplant research aimed to determine whether animal organs might be viable solutions one day, addressing severe shortage of human donor kidneys. Doctors report that the patient is faring well so far, and he stated that he wanted to contribute to the scientific progress. This marks a significant step as clinical xenotransplant trials are about to formally begin. Read More

Other Posts

The UN has released the Co-Chairs' Summary from its first Global Dialogue on AI Governance, held in Geneva in July 2026. The Dialogue brought governments and other stakeholders together to address issues including AI safety, [...]

Six Frankfurt Airport workers contracted malaria this summer after mosquitoes were likely carried into Germany on a flight, and two died. The outbreak prompted a rapid investigation, mosquito trapping, and efforts to determine where the [...]

Applications are now open for the 2026 Bioethics Education International Online Winter School, taking place December 14-18, 2026. This year’s theme, Bioethics in a New World Order, will bring together students and professionals from around [...]

As interest in psychedelic therapy grows, more Americans are traveling abroad for treatments that remain restricted in the United States. Reports of inadequate medical screening, serious complications, and sexual abuse have raised concerns about patient [...]

A new study found that at least one in four former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy, or CTE, a degenerative brain disease associated with repeated head impacts. Researchers [...]

Harvard Business School has launched a $699 AI powered entrepreneurship bootcamp, H.B.S. Foundry, featuring interactive video avatars of its faculty for practicing pitches, sales calls, and board meetings. The AI clones are trained on specific [...]